Erasca, Inc. (ERAS)
NASDAQ: ERAS · Real-Time Price · USD
5.81
+0.64 (12.38%)
At close: Jan 8, 2026, 4:00 PM EST
6.16
+0.35 (6.02%)
After-hours: Jan 8, 2026, 7:59 PM EST
Erasca Market Cap
Erasca has a market cap or net worth of $1.65 billion as of January 8, 2026. Its market cap has increased by 129.54% in one year.
Market Cap
1.65B
Enterprise Value
1.33B
1-Year Change
129.54%
Ranking
Category
Stock Price
$5.81
Market Cap Chart
Since the IPO on July 16, 2021, Erasca's market cap has decreased from $1.86B to $1.65B, a decrease of -11.30%. That is a compound annual growth rate of -2.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 8, 2026 | 1.65B | 56.18% |
| Dec 31, 2025 | 1.06B | 48.72% |
| Dec 31, 2024 | 709.65M | 121.27% |
| Dec 29, 2023 | 320.72M | -50.41% |
| Dec 30, 2022 | 646.73M | -65.76% |
| Dec 31, 2021 | 1.89B | 1.66% |
| Jul 16, 2021 | 1.86B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 971.66B |
| Johnson & Johnson | 495.71B |
| AbbVie | 396.12B |
| UnitedHealth Group | 314.19B |
| AstraZeneca | 295.31B |
| Merck & Co. | 275.48B |
| Novartis AG | 273.11B |
| Novo Nordisk | 256.73B |